Eligibility criteria
Condition
Major Depressive Disorder
Sex
Females and Males
Age
18-75 years
Inclusion criteria
Show details
- Outpatients.
- Sexually active individuals participating in the study must use a medically acceptable
form of contraception during the study and for at least 15 days after the last dose of
test article
- Subjects must have a primary diagnosis of major depressive disorder
Exclusion criteria
Show details
- Treatment with DVS-233 SR at any time in the past
- Treatment with venlafaxine (immediate release [IR] or ER) within 90 days of study day
1
- Known hypersensitivity to venlafaxine (IR or ER)